Mukherji, Reetu
Yin, Chao
Hameed, Rumaisa
Alqahtani, Ali Z.
Kulasekaran, Monika
He, Aiwu R.
Weinberg, Benjamin A.
Marshall, John L.
Hartley, Marion L.
Noel, Marcus S.
Article History
Received: 6 January 2022
Accepted: 19 February 2022
First Online: 6 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: CY, None; RM, None; RH, None; AZA, None; MK, None; ARH, Grant or research support-Merck (Merck Sharp & Dohme a subsidiary of Merck & Co, Inc.), grant or research support-Genentech, Inc., Speakers Bureau-Eisai, Speakers Bureau-BMS; BAW, Personal fees from Taiho, Lilly, Sirtex, Bayer, and Daiichi Sankyo/AstraZeneca, and grants from Ipsen outside the submitted work; JLM, Honoraria—Pfizer, Inc., and Daiichi Sankyo, Inc. Advisor—Bayer Corporation, and Taiho Oncology; MLH, None; MSN: Support from Ipsen outside the submitted work.